Stepan Reports Q4 Revenue of $553.89M
Reports Q4 revenue $553.89M vs. $525.61M last year. "2025 was a transformational year for Stepan as we divested two plant sites and completed preliminary work that has positioned us to further optimize our footprint and asset base in 2026. Despite many challenges in 2025, we delivered growth in several of our core businesses, advanced several strategic initiatives and have an operational plan in place to accelerate profitable growth moving forward. Full year adjusted EBITDA grew 6% versus prior year despite a significant increase in oleochemical raw material costs and start-up expenses at our Pasadena site. Volume grew 1%, organic volume grew 2% and net sales were up 7% driven by pricing actions and favorable product and customer mix. We delivered $25.4 million of free cash flow and increased our dividend for the 58th consecutive year, while reducing our Net Debt by $31.7 million and our Leverage Ratio to 2.5," said Luis E. Rojo, President and CEO. "Fourth quarter adjusted EBITDA was down 3% primarily due to a challenging North American Surfactant environment. We continue to recover margins in Surfactants despite an unprecedented run-up in raw material costs. Polymer volume was up 11% as our Rigid, Specialty Polyols and Phthalic Anhydride businesses all delivered volume growth. I want to personally thank all of our Stepan colleagues around the world for their hard work and resilience during the year."
Trade with 70% Backtested Accuracy
Analyst Views on SCL
About SCL
About the author

- Dividend Increase: Stepan Company has declared a quarterly dividend of $0.395 per share, representing a 2.6% increase from the previous $0.385, indicating the company's ongoing commitment to stable cash flow and shareholder returns, which is likely to boost investor confidence.
- Yield Metrics: The forward yield of this dividend stands at 3.0%, providing investors with a relatively attractive return rate, reflecting the company's financial health in the current economic environment.
- Record Dates: The dividend will be payable on June 15, with a record date of June 1 and an ex-dividend date also set for June 1, offering investors a clear timeline for their investment decisions.
- Cost Savings Initiative: Stepan is implementing a $100 million cost savings plan, which is expected to drive EBITDA growth in 2026 amid restructuring efforts, demonstrating the company's strategic commitment to optimizing operations and enhancing profitability.
- Performance Overview: Stepan Company's Q1 Non-GAAP EPS of $0.45 beats expectations by $0.06, indicating some resilience in profitability despite market pressures.
- Revenue Performance: The revenue for Q1 stands at $604.51 million, reflecting a 1.9% year-over-year increase, yet it misses expectations by $7.74 million, highlighting challenges in market demand.
- Adjusted EBITDA Decline: Adjusted EBITDA is reported at $49.6 million, down 14% year-over-year, suggesting pressures on cost control and profitability that may impact future investment decisions.
- Cash Flow Situation: Cash from operations was $16.9 million, while free cash flow was negative $14.0 million, indicating challenges in cash management that could affect the company's financial flexibility moving forward.
- Significant Stock Surge: Albemarle (ALB) shares soared 16.3% in the last trading session to close at $215.62, with trading volume significantly exceeding normal levels, indicating strong market confidence in its future performance.
- Lithium Price Rebound: The global rebound in lithium prices, driven by robust demand and tight supply, particularly from electric vehicles and energy storage systems, is expected to further enhance ALB's performance, creating a positive feedback loop.
- Strong Earnings Expectations: Albemarle is projected to report quarterly earnings of $1.00 per share, reflecting a staggering year-over-year increase of 655.6%, with revenues expected to reach $1.29 billion, up 19.7% from the previous year, showcasing the company's strong profitability.
- Upward Earnings Revisions: Over the past 30 days, the consensus EPS estimate for ALB has been revised 2.7% higher, and such positive earnings estimate revisions are typically correlated with stock price appreciation, prompting investors to monitor its future performance closely.










